InvestorsHub Logo
Followers 5
Posts 148
Boards Moderated 0
Alias Born 06/16/2016

Re: BeeDoubleU post# 18034

Wednesday, 07/11/2018 12:40:15 PM

Wednesday, July 11, 2018 12:40:15 PM

Post# of 21373
Gynecological cancers are first, but if you check page 14 of the presentation, they mention, "Prolanta™ Breast Cancer: To be pursued with a pharmaceutical partner or post-approval of ovarian indication"
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.